Further Results From the FEELING Study Published

Further Results From the FEELING Study Published By Özge Özkaya

Some women are more likely to develop deep infiltrating endometriosis according to the further analysis of the results of the FEELING study. These are women who: are married, are older,  have siblings,  have had a prior pregnancy,  or for whom…

Key Points Lay Summary

IVF Is the Best Option to Become Pregnant for Women with Severe Endometriosis, or Is It Not?

IVF Is the Best Option to Become Pregnant for Women with Severe Endometriosis, or Is It Not? By Özge Özkaya

Treating rectal endometriosis with surgery seems to increase the chance of a woman conceiving, with most pregnancies occurring naturally. This is according to a study published in the medical journal Human Reproduction.  The optimal treatment for women with severe endometriosis…

Key Points Lay Summary

N-acetyl cysteine, alpha lipoic acid and bromelain improved endometriosis-associated pelvic pain

N-acetyl cysteine, alpha lipoic acid and bromelain improved endometriosis-associated pelvic pain By Yu Yu

Oxidative stress has been implicated in many processes that lead to the development and progression of endometriosis. Typically, women with endometriosis have to endure pelvic pain which negatively impacts their quality of life. Pelvic pain can be chronic and related…

Key Points Lay Summary

Treatment of Endometriosis in Adolescents

Treatment of Endometriosis in Adolescents By Özge Özkaya

Most women with endometriosis who have been treated with Lupron plus add back as adolescents felt the treatment was effective in reducing the pain caused by the condition, according to a study published in the Journal of Pediatric & Adolescent…

Key Points Lay Summary

"New Pain Dairy" Could Help Better Evaluate the Impact of Endometriosis on Women’s Daily Lives

By Özge Özkaya

Researchers developed a new patient-reported endometriosis pain daily diary.  The diary can help evaluate endometriosis-related pain and the impacts this can have on patients' lives as well as be used in clinical trials to assess patients’ response to treatment. “The…

Key Points Lay Summary

Elagolix (ABT-620) for endometriosis pain?

Elagolix (ABT-620) for endometriosis pain? By Yu Yu

Elagolix is an orally active gonadotropin-releasing hormone antagonist that has just recently completed Phase 3 clinical trial for endometriosis-associated pain (NCT01931670). The review article by Alessandro et al in Archives of Gynecology and Obstetrics summarized the current research findings on…

Key Points Lay Summary